Quest Diagnostics, Inc.

Quest Diagnostics, Inc.

DGX

Market Cap$18.84B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Quest Diagnostics, Inc.Quest Diagnostics, Inc.21.51.78%19%21
$178.63

Target Price by Analysts

4% upsideQuest Diagnostics Target Price DetailsTarget Price
$164.04

Current Fair Value

4.5% downside

Overvalued by 4.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$18.84 Billion
Enterprise Value$25.21 Billion
Dividend Yield$3 (1.77756710315814%)
Earnings per Share$7.8
Beta0.89
Outstanding Shares111,000,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio21.51
PEG137.65
Price to Sales1.95
Price to Book Ratio2.82
Enterprise Value to Revenue2.55
Enterprise Value to EBIT22.63
Enterprise Value to Net Income19
Total Debt to Enterprise0.27
Debt to Equity1.02

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Quest Diagnostics, Inc.

47,000 employees
CEO: Stephen Rusckowski

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...